These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11160618)

  • 21. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y; Toyoshima R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding-site crevice.
    Javitch JA; Li X; Kaback J; Karlin A
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10355-9. PubMed ID: 7937955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
    Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
    Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of amino acid determinants of dopamine 2 receptor synthetic agonist function.
    Al-Fulaij MA; Ren Y; Beinborn M; Kopin AS
    J Pharmacol Exp Ther; 2007 Apr; 321(1):298-307. PubMed ID: 17204745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ring substituents on substituted benzamide ligands indirectly mediate interactions with position 7.39 of transmembrane helix 7 of the D4 dopamine receptor.
    Ericksen SS; Cummings DF; Teer ME; Amdani S; Schetz JA
    J Pharmacol Exp Ther; 2012 Aug; 342(2):472-85. PubMed ID: 22588261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors.
    Lane JR; Powney B; Wise A; Rees S; Milligan G
    J Pharmacol Exp Ther; 2008 Apr; 325(1):319-30. PubMed ID: 18218829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist.
    Nakane M; Cowart MD; Hsieh GC; Miller L; Uchic ME; Chang R; Terranova MA; Donnelly-Roberts DL; Namovic MT; Miller TR; Wetter JM; Marsh K; Stewart AO; Brioni JD; Moreland RB
    Neuropharmacology; 2005 Jul; 49(1):112-21. PubMed ID: 15992586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
    Barrondo S; Sallés J
    Neuropharmacology; 2009 Feb; 56(2):455-62. PubMed ID: 18951909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes.
    Wedemeyer C; Goutman JD; Avale ME; Franchini LF; Rubinstein M; Calvo DJ
    Eur J Pharmacol; 2007 May; 562(3):165-73. PubMed ID: 17350612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of the antipsychotic drug pipamperone on the expression of the dopamine D4 receptor.
    Van Craenenbroeck K; Gellynck E; Lintermans B; Leysen JE; Van Tol HH; Haegeman G; Vanhoenacker P
    Life Sci; 2006 Dec; 80(1):74-81. PubMed ID: 16978659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice.
    Javitch JA; Fu D; Chen J
    Biochemistry; 1995 Dec; 34(50):16433-9. PubMed ID: 8845371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexras1 blocks receptor-mediated heterologous sensitization of adenylyl cyclase 1.
    Nguyen CH; Watts VJ
    Biochem Biophys Res Commun; 2005 Jul; 332(3):913-20. PubMed ID: 15913563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites.
    Plenge P; Gether U; Rasmussen SG
    Eur J Pharmacol; 2007 Jul; 567(1-2):1-9. PubMed ID: 17499240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intramolecular allosteric communication in dopamine D2 receptor revealed by evolutionary amino acid covariation.
    Sung YM; Wilkins AD; Rodriguez GJ; Wensel TG; Lichtarge O
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3539-44. PubMed ID: 26979958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dopamine D4 receptors and mechanisms of antipsychotic atypicality.
    Wong AH; Van Tol HH
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1091-9. PubMed ID: 14642969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of dopamine D-receptor activation in vivo by protein phosphatase 2B (calcineurin).
    Adlersberg M; Hsiung SC; Glickstein SB; Liu KP; Tamir H; Schmauss C
    J Neurochem; 2004 Aug; 90(4):865-73. PubMed ID: 15287892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
    Millan MJ; Cussac D; Gobert A; Lejeune F; Rivet JM; Mannoury La Cour C; Newman-Tancredi A; Peglion JL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):903-20. PubMed ID: 14978194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [35S]GTPgammaS binding at the human dopamine D4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine.
    Czermak C; Lehofer M; Liebmann PM; Traynor J
    Eur J Pharmacol; 2006 Feb; 531(1-3):20-4. PubMed ID: 16423344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective reconstitution of human D4 dopamine receptor variants with Gi alpha subtypes.
    Kazmi MA; Snyder LA; Cypess AM; Graber SG; Sakmar TP
    Biochemistry; 2000 Apr; 39(13):3734-44. PubMed ID: 10736173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new approach to finding specific dopamine D4 receptor agonists.
    Morishita H; Shibata K; Sakata N; Kita S; Katsuragi T
    Eur J Pharmacol; 2005 Jun; 516(2):145-50. PubMed ID: 15922324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.